LTRN — Lantern Pharma Cashflow Statement
0.000.00%
Last trade - 00:00
- $40.64m
- $7.37m
- 43
- 28
- 20
- 21
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.43 | -5.91 | -12.4 | -14.3 | -16 |
Depreciation | |||||
Non-Cash Items | 0.118 | 1.19 | 1.16 | 2.09 | 1.06 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.181 | -0.939 | 0.6 | -0.612 | 0.538 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -2.13 | -5.65 | -10.6 | -12.8 | -14.3 |
Capital Expenditures | -0.006 | -0.016 | -0.015 | -0.028 | -0.019 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | -19.5 | 0.207 | -0.911 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.006 | -0.016 | -19.5 | 0.179 | -0.93 |
Financing Cash Flow Items | 0 | -2.75 | -4.78 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.92 | 23.7 | 63.4 | -2.18 | -0.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.787 | 18 | 33.3 | -14.8 | -15.8 |